These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9236923

  • 41. Association of immunohistochemical p53 tumor suppressor gene protein overexpression with prognosis in highly proliferative human mammary adenocarcinomas.
    Schimmelpenning H, Eriksson ET, Zetterberg A, Auer GU.
    World J Surg; 1994; 18(6):827-32; discussion 832-3. PubMed ID: 7846904
    [Abstract] [Full Text] [Related]

  • 42. Expression of JMJD2A in infiltrating duct carcinoma was markedly higher than fibroadenoma, and associated with expression of ARHI, p53 and ER in infiltrating duct carcinoma.
    Li BX, Li J, Luo CL, Zhang MC, Li H, Li LL, Xu HF, Shen YW, Xue AM, Zhao ZQ.
    Indian J Exp Biol; 2013 Mar; 51(3):208-17. PubMed ID: 23678541
    [Abstract] [Full Text] [Related]

  • 43. Assessment of proliferating cell nuclear antigen activity using digital image analysis in breast carcinoma following magnetic resonance-guided interstitial laser photocoagulation.
    Korourian S, Klimberg S, Henry-Tillman R, Lindquist D, Jones M, Eng DC, Helsel JC, Mumtaz H, Westbrook K, Harms S.
    Breast J; 2003 Mar; 9(5):409-13. PubMed ID: 12968963
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.
    Hu TH, Wang CC, Huang CC, Chen CL, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Tai MH.
    Oncol Rep; 2007 Dec; 18(6):1417-26. PubMed ID: 17982625
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Overexpression of p53 protein and proliferative activity in colorectal adenoma.
    Yamaguchi A, Makimoto K, Goi T, Takeuchi K, Maehara M, Isobe Y, Nakagawara G.
    Oncology; 1994 Dec; 51(3):224-7. PubMed ID: 7910956
    [Abstract] [Full Text] [Related]

  • 50. Localization of p53 and proliferating cell nuclear antigen in fine-needle aspirates of benign and primary malignant tumors of the human breast: an immunocytochemical study using supersensitive monoclonal antibodies and the biotin-streptavidin-amplified method.
    Alexiev BA.
    Diagn Cytopathol; 1996 Nov; 15(4):277-81. PubMed ID: 8982580
    [Abstract] [Full Text] [Related]

  • 51. The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer.
    Bhargava V, Thor A, Deng G, Ljung BM, Moore DH, Waldman F, Benz C, Goodson W, Mayall B, Chew K.
    Mod Pathol; 1994 Apr; 7(3):361-8. PubMed ID: 8058709
    [Abstract] [Full Text] [Related]

  • 52. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
    Bánkfalvi A, Tory K, Kemper M, Breukelmann D, Cubick C, Poremba C, Füzesi L, Lellè RJ, Böcker W.
    Pathol Res Pract; 2000 Apr; 196(7):489-501. PubMed ID: 10926327
    [Abstract] [Full Text] [Related]

  • 53. Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer.
    Shapochka DO, Zaletok SP, Gnidyuk MI.
    Exp Oncol; 2012 Dec; 34(4):358-63. PubMed ID: 23302996
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Prospective studies of p53 and c-erbB-2 expression in relation to clinicopathological parameters of human ductal breast cancer in the second stage of clinical advancement.
    Bebenek M, Bar JK, Harlozinska A, Sedlaczek P.
    Anticancer Res; 1998 Dec; 18(1B):619-23. PubMed ID: 9568187
    [Abstract] [Full Text] [Related]

  • 57. [Expression of PTEN, p53 and EGFR in the molecular subtypes of breast carcinoma and 
the correlation among them].
    Li X, Wang Q, Fu L, Liu M, Yu X.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 40(9):973-8. PubMed ID: 26408616
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.